Lupin Healthcare, a wholly owned subsidiary of Slough-based Lupin, has acquired a pharmaceutical company which is the sole supplier of four specialty products addressing unmet medical needs in the UK.

Indian drug major Lupin on Wednesday said it has acquired the UK-based Renascience Pharma in a deal worth £12.3 million (around ₹135 crore). The acquisition was completed via Lupin ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...